CAS: 81965-43-7 - 2-[[[(2-Chloroethyl)nitrosoamino]carbonyl]methylamino]acetamide
Formula:C6H11ClN4O3
InChI:InChI=1S/C6H11ClN4O3/c1-10(4-5(8)12)6(13)11(9-14)3-2-7/h2-4H2,1H3,(H2,8,12)
InChI key:InChIKey=HYHJFNXFVPGMBI-UHFFFAOYSA-N
SMILES:O=NN(C(=O)N(C)CC(=O)N)CCCl
- Synonyms:
- SarCNU
- N2-[N-(2-Chloroethyl)-N-nitrosocarbamoyl]sarcosinamide
- N~2~-[(2-chloroethyl)(nitroso)carbamoyl]-N~2~-methylglycinamide
- SarCNU
- 2-[[[(2-Chloroethyl)nitrosoamino]carbonyl]methylamino]acetamide
- NSC-364432
- Acetamide, 2-[[[(2-chloroethyl)nitrosoamino]carbonyl]methylamino]-
- Sarcosinamide chloroethylnitrosourea
- NSC 364432
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Sarmustine REF: TM-T28663CAS: 81965-43-7 | 100% - 99.71% | 185.00 €~1,859.00 € | Mon 27 Jan 25 |
Sarmustine
CAS:81965-43-7
SarCNU is an alkylating anticancer drug targeting prostate cancer through p53 pathways and selects P140K …
Formula:
C6H11ClN4O3
Purity:
100% - 99.71%
Color and Shape:
Solid
Molecular weight:
222.63
Ref: TM-T28663
1mg | 185.00 € | ||
5mg | 456.00 € | ||
10mg | 653.00 € | ||
25mg | 1,020.00 € | ||
50mg | 1,406.00 € | ||
100mg | 1,859.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025